Table 3 Concentration range of urinary LAM measured using MoAb1, CS35 and A194 mAbs, ng/mL (IQR).
From: Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes
Median LAM concentration, ng/mL (IQR) | |||||
|---|---|---|---|---|---|
Tot # | MoAb1 | CS35 | A194 | Combination | |
TB positive | 219 | 0.5 (1.50) | 0.46 (1.52) | 0.20 (0.32) | 0.48 (1.08) |
Adults | 200 | 0.51 (1.60) | 0.48 (1.57) | 0.19 (0.31) | 0.52 (1.10) |
Pediatric | 19 | 0.46 (0.91) | 0.23 (0.62) | 0.07 (0.41) | 0.14 (0.24) |
PTB | 195 | 0.46 (0.54) | 0.45 (1.54) | 0.20 (0.31) | 0.45 (1.00) |
EPTP | 24 | 1.40 (1.83) | 0.84 (1.24) | 0.194 (0.25) | 0.73 (1.47) |
HIV status | |||||
Positive | 55 | 0.46 (1.62) | 1.19 (3.21) | 0.30 (0.36) | 0.79 (1.45) |
Negative | 164 | 0.52 (1.56) | 0.55 (1.21) | 0.13 (0.14) | 0.40 (0.83) |
Glycosuria | |||||
Positive | 24 | 0.76 (1.78) | 0.21 (0.43) | 0.11 (0.26) | 0.44 (0.68) |
Negative | 195 | 0.49 (1.55) | 0.56 (1.61) | 0.20 (0.31) | 0.47 (1.09) |
Countries | |||||
Peru | 80 | 0.35 (1.19) | 0.23 (0.89) | 0.13 (0.22) | 0.35 (0.66) |
Guinea Bissau | 17 | 0.54 (1.63) | 0.004 (0.23) | 0.031 (0.06) | 0.31 (0.62) |
Uganda | 97 | 0.46 (1.30) | 0.83 (2.22) | 0.28 (0.37) | 0.66 (1.39) |
Venezuela | 25 | 1.59 (1.78) | 0.93 (1.17) | 0.24 (0.40) | 0.87 (1.46) |
